Enzyme agent for carboxy group generation and application thereof

A novel enzymatic agent with carboxyl group-generating activity addresses the inefficiencies and environmental concerns of existing dicarboxylic acid production methods by efficiently converting fatty acids into dicarboxylic acids, offering a cost-effective and environmentally friendly solution.

WO2024232406A1PCT designated stage expired Publication Date: 2024-11-14AMANO ENZYME INC
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2024/017215
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-10
Filing Date
2024-05-09
Publication Date
2024-11-14

AI Technical Summary

Technical Problem

Current methods for producing dicarboxylic acids, such as chemical synthesis using petroleum raw materials and microbial fermentation, face environmental concerns and challenges in controlling microorganisms, while enzymatic methods require costly cofactors or mediators, limiting their practicality and efficiency.

Method used

Development of a novel enzymatic agent comprising specific polypeptides with carboxyl group-generating activity, derived from basidiomycetes, which can produce dicarboxylic acids by acting on fatty acids, offering a cost-effective and efficient alternative.

Benefits of technology

The novel enzymatic agent enables the production of dicarboxylic acids with high utility value, reducing production costs and environmental impact, and providing a method for producing carboxylic acids and dicarboxylic acids with improved efficiency and control.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JPOXMLDOC01-APPB-T000001
    Figure JPOXMLDOC01-APPB-T000001
  • Figure JPOXMLDOC01-APPB-T000002
    Figure JPOXMLDOC01-APPB-T000002
  • Figure JPOXMLDOC01-APPB-T000003
    Figure JPOXMLDOC01-APPB-T000003
Patent Text Reader

Abstract

The present invention addresses the problem of providing a novel enzyme having carboxy group generation activity. The present invention relates to an enzyme agent for carboxy group generation, the enzyme agent comprising a polypeptide represented by any one of (1) to (3) below. (1) A polypeptide comprising the amino acid sequence represented by any one of SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10, and 11. (2) A polypeptide comprising the amino acid sequence represented by any one of SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10, and 11, where one or several amino acid residues are substituted, added, inserted and / or deleted, the polypeptide having a carboxy group generation activity. (3) A polypeptide having at least 90% sequence identity with the amino acid sequence represented by any one of SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10, and 11, and having carboxy group generation activity.
Need to check novelty before this filing date? Find Prior Art

Description

Carboxy group generating enzyme preparations and their applications

[0001] The present invention relates to a novel enzymatic preparation for generating carboxyl groups. The present invention also relates to a method for producing a polycarboxylic acid-containing composition, a method for carboxylating fatty acids, and a method for producing a polycarboxylic acid-containing food using the enzymatic preparation for generating carboxyl groups.

[0002] Carboxylic acids are used as key raw materials for chemical products. Dicarboxylic acids, in particular, are used as raw materials for polymers such as polyamides and polyesters, plasticizers, lubricants, fragrances, and more. For example, sebacic acid, a type of dicarboxylic acid, is used as a raw material for 6,10-nylon. Brassylic acid is also used as a raw material for ethylene brassylate, a musk fragrance.

[0003] Chemical synthesis using petroleum feedstocks and microbial fermentation are known methods for producing dicarboxylic acids. For example, Patent Document 1 discloses a method for producing long-chain dicarboxylic acids, which includes culturing a microorganism in a medium to which a fatty acid ester as a substrate and a water-soluble alcohol as a carbon source are added. However, chemical synthesis using petroleum feedstocks has the problem of environmental impact, and production of dicarboxylic acids using microbial fermentation has the problem of difficulty in controlling the microorganisms and of contamination with metabolites derived from the microorganisms. Therefore, a simpler method that imposes less of a burden on the environment is desired.

[0004] One known method for producing dicarboxylic acids is to allow an enzyme to act on a fatty acid. For example, Patent Document 2 and Non-Patent Document 1 report that dicarboxylic acids such as azalic acid can be obtained by allowing laccase to act on a fatty acid in the presence of a mediator such as 1-hydroxybenzotriazole. Non-Patent Document 2 also reports that the dicarboxylic acid hexadecanedioic acid can be obtained by allowing cytochrome P450 52A3 to act on hexadecane.

[0005] Furthermore, Non-Patent Document 3 reports that dicarboxylic acids such as azelaic acid and brassylic acid can be obtained by allowing peroxygenase (MroUPO) produced by Marasmius rotula to act on decanoic acid or myristic acid. Also, Non-Patent Document 4 reports that dicarboxylic acids that are two carbon atoms smaller can be obtained by allowing peroxygenase (AaeUPO) produced by Agrocybe aegerita or peroxygenase (rCciUPO) derived from Coprinopsis cinerea to act on fatty acids such as stearic acid, oleic acid, linoleic acid, and linolenic acid.

[0006] JP 2014-168440 A JP 2006-262728 A

[0007] Bioscience Biotechnology and Biochemistry, 2016 Vol.80, No.11, 2132-2137THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 273, No. 49, Issue of December 4, pp. 32528-32534, 1998Chemistry a European Journal 2017, 23, 1-6Antioxidants 2022, 11, 744

[0008] As mentioned above, carboxylic acids and dicarboxylic acids are expected to be used in a wide range of applications. Various methods for the enzymatic production of dicarboxylic acids have been reported. However, there are problems, such as the need for NADPH as a cofactor in methods using cytochrome P450, and the need for mediators such as 1-hydroxybenzotriazole in methods using laccase catalysts, which leads to increased costs. Furthermore, peroxygenases derived from basidiomycetes are low-cost because they use peroxide as a cofactor, but they have not yet been put to practical use, and further enzyme development is needed.

[0009] Therefore, an object of the present invention is to provide a novel enzyme having carboxyl group-generating activity.

[0010] Examples of specific embodiments of the present invention are given below.

[0011] [1] A carboxyl group-generating enzymatic preparation comprising a polypeptide shown in any one of (1) to (3) below: (1) A polypeptide consisting of the amino acid sequence shown in any one of SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10, and 11; (2) A polypeptide comprising the amino acid sequence shown in any one of SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10, and 11, in which one or several amino acid residues have been substituted, added, inserted, and / or deleted, and which has carboxyl group-generating activity; (3) A polypeptide having 90% or more sequence identity to the amino acid sequence shown in any one of SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10, and 11, and which has carboxyl group-generating activity. [2] The carboxyl group-generating enzymatic preparation according to [1], which is used for generating dicarboxylic acids. [3] A method for producing a polycarboxylic acid-containing composition, which comprises treating a fatty acid-containing composition with the polypeptide or carboxyl group-generating enzymatic preparation according to [1] or [2]. [4] A method for producing a polycarboxylic acid-containing composition according to [3], in which the fatty acid-containing composition contains decanoic acid or myristic acid. [5] A method for producing a polycarboxylic acid-containing composition according to [3] or [4], wherein the polycarboxylic acid-containing composition is a dicarboxylic acid-containing composition. [6] A method for carboxylating a fatty acid, comprising allowing the polypeptide or carboxy group-generating enzymatic agent according to [1] or [2] to act on a fatty acid. [7] A method for producing a polycarboxylic acid-containing food, comprising allowing the polypeptide or carboxy group-generating enzymatic agent according to [1] or [2] to act on a fatty acid-containing food. [8] A method for producing a polycarboxylic acid-containing food according to [7], wherein the polycarboxylic acid-containing food is a dicarboxylic acid-containing food.

[0012] The present invention also has the following configurations. [A] A method for producing a polycarboxylic acid, comprising acting on a fatty acid with a polypeptide described in any one of (1) to (3) above. [B] An enzymatic preparation comprising a polypeptide described in any one of (1) to (3) above, for use in the carboxylation of fatty acids. [C] Use of an enzymatic preparation comprising a polypeptide described in any one of (1) to (3) above for the carboxylation of fatty acids. [D] Use of an enzymatic preparation comprising a polypeptide described in any one of (1) to (3) above for the improvement of foods. [E] A polycarboxylic acid-containing composition produced by the method for producing a polycarboxylic acid-containing composition described in any one of [3] to [5]. [F] A polycarboxylic acid-containing food produced by the method for producing a polycarboxylic acid-containing food described in [7] or [8]. [G] An enzymatic preparation for fatty acid shortening, comprising a polypeptide described in any one of (1) to (3) above. [H] An enzymatic preparation for hydroxyl group generation, comprising a polypeptide described in any one of (1) to (3) above. [I] A method for shortening a fatty acid, comprising acting on a fatty acid with an enzymatic preparation for fatty acid shortening, comprising a polypeptide described in any one of (1) to (3) above. [J] A hydroxylation method or a carboxylation method, which comprises reacting an alkane-containing composition or a fatty acid ester-containing composition with a carboxyl group-generating enzyme agent (hydroxyl group-generating enzyme agent) containing a polypeptide shown in any one of (1) to (3) above.

[0013] According to the present invention, a new enzyme preparation having carboxyl group-generating activity can be provided.

[0014] FIG. 1 shows the results of chromatography when dodecanol was used as the substrate in Test Example 2.

[0015] The present invention will be described in detail below. The following description of the constituent elements may be based on representative embodiments or specific examples, but the present invention is not limited to such embodiments. In this specification, a numerical range expressed using "to" means a range that includes the numerical values ​​before and after "to" as the lower and upper limits.

[0016] In the present specification, the 20 types of amino acid residues in an amino acid sequence may be represented by single-letter abbreviations, such as G for glycine (Gly), A for alanine (Ala), V for valine (Val), L for leucine (Leu), I for isoleucine (Ile), F for phenylalanine (Phe), Y for tyrosine (Tyr), W for tryptophan (Trp), S for serine (Ser), T for threonine (Thr), C for cysteine ​​(Cys), M for methionine (Met), D for aspartic acid (Asp), E for glutamic acid (Glu), N for asparagine (Asn), Q for glutamine (Gln), K for lysine (Lys), R for arginine (Arg), H for histidine (His), and P for proline (Pro). In addition, in the amino acid sequences shown herein, the left end is the N-terminus and the right end is the C-terminus.

[0017] As used herein, "nonpolar amino acids" include alanine, valine, leucine, isoleucine, proline, methionine, phenylalanine, and tryptophan. "Uncharged amino acids" include glycine, serine, threonine, cysteine, tyrosine, asparagine, and glutamine. "Acidic amino acids" include aspartic acid and glutamic acid. "Basic amino acids" include lysine, arginine, and histidine.

[0018] As used herein, the term "substitution" refers not only to cases where an amino acid residue substitution is artificially introduced, but also to cases where an amino acid residue substitution is naturally introduced, i.e., cases where the amino acid residue is originally different. As used herein, the amino acid residue substitution may be either an artificial substitution or a natural substitution, with artificial substitution being preferred.

[0019] (Enzyme preparation for generating a carboxy group) This embodiment relates to an enzymatic preparation for generating a carboxy group, comprising a polypeptide shown in any one of (1) to (3) below. (1) A polypeptide consisting of an amino acid sequence shown in any one of SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10, and 11. (2) A polypeptide having a carboxy group-generating activity, in which one or several amino acid residues have been substituted, added, inserted, and / or deleted in the amino acid sequence shown in any one of SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10, and 11. (3) A polypeptide having a sequence identity of 90% or more to the amino acid sequence shown in any one of SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10, and 11, and having a carboxy group-generating activity.

[0020] The carboxyl group-generating enzymatic preparation of this embodiment contains, as an active ingredient, a polypeptide shown in any one of (1) to (3) above. Note that any one of (1) to (3) above is a carboxyl group-generating enzyme, and the carboxyl group-generating enzymatic preparation may consist of the above-mentioned carboxyl group-generating enzyme.

[0021] In this embodiment, the carboxyl group-generating enzyme agent is preferably used for generating dicarboxylic acids. In this specification, dicarboxylic acid refers to a dicarboxylic acid having carboxy groups at both ends of the carbon chain, such as malonic acid (C3), malic acid (C4), fumaric acid (C4), succinic acid (C4), itaconic acid (C5), glutaric acid (C5), adipic acid (C6), pimelic acid (C7), suberic acid (C8), azelaic acid (C9), sebacic acid (decanoic acid) (C10), undecanedioic acid (C11), dodecanedioic acid (C12), tridecanedioic acid (brassylic acid) (C13), and tetradecanedioic acid (C14). Long-chain dicarboxylic acids are dicarboxylic acids with 10 or more carbon atoms. In this specification, the notation Cx for fatty acids and hydrocarbons indicates that the number of carbon atoms is x. For example, malonic acid (C3) represents a fatty acid with three carbon atoms.

[0022] The carboxyl group-generating enzyme preparation of this embodiment comprises a polypeptide described in any one of (1) to (3) above, and is a novel enzyme preparation having carboxyl group-generating activity. Because carboxylic acids and dicarboxylic acids are expected to be used in a wide range of applications as key raw materials for chemical products, the novel enzyme preparation of this embodiment is highly useful as a new enzyme that generates carboxylic acids and dicarboxylic acids. Furthermore, use of the novel enzyme preparation of this embodiment is expected to lead to the establishment of a low-cost, highly efficient method for generating carboxylic acids and dicarboxylic acids.

[0023] The content of the polypeptide (carboxy group-forming enzyme) shown in any one of (1) to (3) in the carboxy group-generating enzymatic preparation of this embodiment is not particularly limited and can be appropriately set within a range in which appropriate catalytic activity is exhibited, for example, when producing a dicarboxylic acid using a fatty acid as a substrate. The content of the polypeptide (carboxy group-generating enzyme) in the carboxy group-generating enzymatic preparation varies depending on the type, but may be, for example, 0.001 to 50% by mass, 0.01 to 20% by mass, or 0.1 to 10% by mass relative to the total mass of the carboxy group-generating enzymatic preparation.

[0024] The carboxyl group-forming enzyme used in this embodiment is an enzyme that has heme b as a cofactor. Heme b exhibits absorption at a characteristic wavelength when bound to pyridine under alkaline conditions. The molar extinction coefficient at this wavelength (557 nm) is 34.7 mM. -1 cm -1 ) The concentration of heme b is calculated from the above. The enzyme concentration can be calculated by assuming the concentration of heme b to be the enzyme concentration.

[0025] The activity of the carboxyl group-forming enzyme can be determined from the change in absorbance at 469 nm when 5 mM 2,6-dimethoxyphenol solution (0.1 M potassium phosphate / 0.05 M potassium acetate buffer, pH 7.0, 0.5 mM hydrogen peroxide) is used as the substrate and treated at 40° C. In this specification, the amount of enzyme that oxidizes 1 nmol of substrate per minute under the above conditions is defined as 1 unit (1 U).

[0026] The enzymatic preparation for carboxyl group generation of this embodiment may consist of only a carboxyl group generating enzyme, or may contain hydrogen peroxide in addition to the carboxyl group generating enzyme. When the enzymatic preparation for carboxyl group generation contains hydrogen peroxide, the generation of carboxyl groups, for example, the generation of dicarboxylic acids, is promoted.

[0027] Furthermore, the carboxyl group-generating enzyme preparation of this embodiment may contain other components in addition to the carboxyl group-generating enzyme to the extent that the effects of the present invention are not affected. Examples of other components include enzymes other than the carboxyl group-generating enzyme, additives, and culture residues generated in the process of preparing the carboxyl group-generating enzyme.

[0028] Examples of enzymes other than carboxyl group-generating enzymes include amylases (α-amylase, β-amylase, glucoamylase), glucosidases (α-glucosidase, β-glucosidase), galactosidases (α-galactosidase, β-galactosidase), proteases (acid proteases, neutral proteases, alkaline proteases), peptidases (leucine peptidases, aminopeptidases), lipases, esterases, cellulases, phosphatases (acid phosphatases, alkaline phosphatases), nucleases, deaminases, oxidases, dehydrogenases, glutaminase, pectinases, dextranases, transglutaminase, protein deamidating enzymes, pullulanases, peroxidases, etc. These other enzymes may be used alone or in combination.

[0029] Additives that may be contained in the carboxyl group-generating enzyme preparation include excipients, buffers, suspending agents, stabilizers, preservatives, antiseptics, physiological saline, etc. Excipients include starch, dextrin, maltose, trehalose, lactose, D-glucose, sorbitol, D-mannitol, sucrose, glycerol, etc. Buffers include phosphates, citrates, acetates, etc. Stabilizers include propylene glycol, ascorbic acid, etc. Preservatives include phenol, benzalkonium chloride, benzyl alcohol, chlorobutanol, methylparaben, etc. Preservatives include ethanol, benzalkonium chloride, parahydroxybenzoic acid, chlorobutanol, etc. These additives may be used alone or in combination.

[0030] The form of the carboxyl group-generating enzyme agent of this embodiment is not particularly limited, and examples thereof include powder, solid, gel, liquid (slurry), and immobilized on a carrier.

[0031] (Polypeptide (carboxy group-generating enzyme)) The enzyme preparation for carboxy group generation of this embodiment comprises a polypeptide shown in any one of the following (1) to (3). The polypeptide shown in any one of the following (1) to (3) has carboxy group-generating activity and is a carboxy group-generating enzyme. (1) A polypeptide consisting of an amino acid sequence shown in any one of SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10 and 11. (2) A polypeptide having carboxy group-generating activity, in which one or several amino acid residues have been substituted, added, inserted and / or deleted in the amino acid sequence shown in any one of SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10 and 11. (3) A polypeptide having 90% or more sequence identity to the amino acid sequence shown in any one of SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10 and 11 and having carboxy group-generating activity.

[0032] The type of carboxyl group-generating enzyme is not particularly limited, and examples thereof include carboxyl group-generating enzymes derived from basidiomycetes. Preferred examples of carboxyl group-generating enzymes include those derived from the genus Marasmius, those derived from the genus Dendrothele, those derived from the genus Mycena, and those derived from the genus Armillaria. More preferred examples include those derived from Marasmius fiardii, those derived from Dendrothele bispora, those derived from Mycena venus, and those derived from Armillaria ostyae. The carboxyl group-generating enzyme preparation may contain one or more types of carboxyl group-generating enzymes. The carboxyl group-generating enzyme preparation may be a single agent or two or more agents.

[0033] Among these, it is preferred that the polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 1 is a carboxyl group-forming enzyme derived from Marasmius fiardii, the polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 4 is a carboxyl group-forming enzyme derived from Dendrothele bispora, the polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 7 is a carboxyl group-forming enzyme derived from Mycena venus, and the polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 10 is a carboxyl group-forming enzyme derived from Armillaria ostoyae.

[0034] The amino acid sequence shown in SEQ ID NO: 2 has a polyhistidine tag added to the C-terminus of the amino acid sequence shown in SEQ ID NO: 1, the amino acid sequence shown in SEQ ID NO: 5 has a polyhistidine tag added to the C-terminus of the amino acid sequence shown in SEQ ID NO: 4, the amino acid sequence shown in SEQ ID NO: 8 has a polyhistidine tag added to the C-terminus of the amino acid sequence shown in SEQ ID NO: 7, and the amino acid sequence shown in SEQ ID NO: 11 has a polyhistidine tag added to the C-terminus of the amino acid sequence shown in SEQ ID NO: 10. The amino acid sequence shown in SEQ ID NO: 3 is the amino acid sequence shown in SEQ ID NO: 1 with a polyhistidine tag added to the C-terminus and a signal sequence added to the N-terminus, the amino acid sequence shown in SEQ ID NO: 6 is the amino acid sequence shown in SEQ ID NO: 4 with a polyhistidine tag added to the C-terminus and a signal sequence added to the N-terminus, the amino acid sequence shown in SEQ ID NO: 9 is the amino acid sequence shown in SEQ ID NO: 7 with a polyhistidine tag added to the C-terminus and a signal sequence added to the N-terminus, and the amino acid sequence shown in SEQ ID NO: 12 is the amino acid sequence shown in SEQ ID NO: 10 with a polyhistidine tag added to the C-terminus and a signal sequence added to the N-terminus. The carboxyl group-generating enzymatic preparation of this embodiment may comprise a polypeptide consisting of an amino acid sequence shown in any of SEQ ID NOs: 1 to 12.

[0035] The polypeptide of (2) above is a polypeptide comprising one or several amino acid residues substituted, added, inserted, and / or deleted in the amino acid sequence of any of SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10, and 11, and having carboxyl group-generating activity. The amino acid modification may be introduced at any difference site. Furthermore, the amino acid modification may be one type of modification selected from substitution, addition, insertion, and deletion (e.g., substitution only), or two or more types of modifications (e.g., substitution and insertion). In the polypeptide of (2) above, the number of amino acid differences at any difference site may be one or several. The number of differences may be, for example, 1 to 80, 1 to 70, 1 to 60, 1 to 50, 1 to 40, 1 to 30, 1 to 20, 1 to 10, 1 to 8, 1 to 7, 1 to 6, 1 to 5, 1 to 4, 1 to 3, or 1 to 2. The amino acid sequence shown in SEQ ID NO: 3 is the amino acid sequence shown in SEQ ID NO: 2 to which a signal sequence has been added, and therefore corresponds to the polypeptide to which several amino acid residues have been added as described in (2) above. Similarly, SEQ ID NOs: 6, 9, and 12 each correspond to a polypeptide to which several amino acid residues have been added.

[0036] The polypeptide of (3) above preferably has a sequence identity of 60% or more, more preferably 70% or more, even more preferably 80% or more, still more preferably 90% or more, even more preferably 95% or more, particularly preferably 97% or more, and most preferably 99% or more to any of the amino acid sequences set forth in SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10, and 11. The polypeptide of (3) above also has carboxyl group-generating activity.

[0037] In the polypeptide (3) above, the sequence identity to any of the amino acid sequences shown in SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10, and 11 is the sequence identity calculated by comparing with any of the amino acid sequences shown in SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10, and 11. As used herein, the term "sequence identity" refers to the amino acid sequence identity value obtained by the bl2seq program (Tatiana A. Tatsusova, Thomas L. Madden, FEMS Microbiol. Lett., Vol. 174, pp. 247-250, 1999) of BLASTPACKAGE [sgi32 bit edition, Version 2.0.12; available from the National Center for Biotechnology Information (NCBI)]. The parameters are calculated by setting Gap insertion cost value: 11, Gap extension cost value: 1.

[0038] When an amino acid substitution is introduced at any difference site in the polypeptides (2) and (3) above, a preferred embodiment of the amino acid substitution to be introduced is a conservative substitution. Examples of the amino acid substitution in the polypeptides (2) and (3) above include substitution of a nonpolar amino acid with another nonpolar amino acid if the amino acid before substitution is a nonpolar amino acid, substitution of an uncharged amino acid with another uncharged amino acid if the amino acid before substitution is an acidic amino acid with another acidic amino acid, and substitution of a basic amino acid with another basic amino acid if the amino acid before substitution is a basic amino acid.

[0039] In the polypeptides of (2) and (3) above, the amino acid residues corresponding to positions 23 (cysteine ​​residue), 94 (histidine residue), and 165 (aspartic acid residue) in the amino acid sequence shown in SEQ ID NO: 1; positions 26 (cysteine ​​residue), 95 (histidine residue), and 166 (aspartic acid residue) in the amino acid sequence shown in SEQ ID NO: 4; positions 20 (cysteine ​​residue), 89 (histidine residue), and 161 (aspartic acid residue) in the amino acid sequence shown in SEQ ID NO: 7; and positions 21 (cysteine ​​residue), 90 (histidine residue), and 161 (aspartic acid residue) in the amino acid sequence shown in SEQ ID NO: 10 are considered to be active catalytic residues, and therefore it is desirable not to introduce substitutions or deletions at these positions. In the present specification, amino acid residues other than those corresponding to the above-mentioned active catalytic residues in the polypeptides of (2) and (3) above may also be referred to as "arbitrary difference sites." As used herein, an "arbitrary difference site" refers to a site where a difference is permitted as long as it does not significantly affect the properties of the polypeptide. A polypeptide that has a difference in amino acid sequence at an arbitrary difference site but has carboxyl group-generating activity at or above the same level as the polypeptide (1) above is called a variant of the polypeptide (1) above. In other words, the polypeptides (2) and (3) above are variants of the polypeptide (1) above.

[0040] The polypeptides (1) to (3) above may be part of a larger protein (e.g., a fusion protein). Additional sequences in the fusion protein may include sequences that aid in purification, such as multiple histidine residues, or additional sequences that ensure stability during recombinant production.

[0041] (DNA) The nucleotide sequences encoding the polypeptides consisting of the amino acid sequences shown in SEQ ID NOs: 1 to 12 are respectively shown in SEQ ID NOs: 13 to 24. The nucleotide sequences encoding the polypeptides consisting of the amino acid sequences shown in SEQ ID NOs: 1 to 12 include sequences equivalent to the nucleotide sequences shown in SEQ ID NOs: 13 to 24.

[0042] For sequences equivalent to the nucleotide sequences shown in SEQ ID NOs: 13 to 24, the homology to the nucleotide sequences shown in SEQ ID NOs: 13 to 24 is preferably 75% or more, more preferably 80% or more, even more preferably 85% or more, even more preferably 90% or more, even more preferably 95% or more, and particularly preferably 99% or more. Even if a DNA has a sequence different from any of the nucleotide sequences shown in SEQ ID NOs: 13 to 24, it can be said to be equivalent to any of the nucleotide sequences shown in SEQ ID NOs: 13 to 24 as long as it encodes a polypeptide having carboxyl group-generating activity.

[0043] The "homology" of nucleotide sequences is calculated using publicly available or commercially available software with an algorithm for comparing a reference sequence with a query sequence. Specifically, BLAST, FASTA, or GENETYX (Software Development Co., Ltd.) can be used, and these may be used with default parameters.

[0044] DNAs having the nucleotide sequences shown in SEQ ID NOs: 13 to 24 or equivalent DNAs can also be isolated from microorganisms that produce the above-mentioned polypeptides. For example, the target DNA can be isolated from the genome of the above-mentioned microorganism by PCR or hybridization using the genomic DNA of Marasmius fiardii PR as a template and primers or probes designed from known amino acid sequence information taking gene degeneracy into consideration, or primers or probes designed based on known nucleotide sequence information.

[0045] DNAs having the nucleotide sequences set forth in SEQ ID NOS: 13 to 24 or equivalent DNAs may be artificially synthesized genes. In this case, for example, artificially synthesized genes can be prepared by optimizing codons based on the codon frequency of Aspergillus oryzae. DNA encompasses various types of DNA resulting from codon degeneracy. Artificially preparing various types of DNA encoding the same amino acid sequence can be easily achieved using known genetic engineering techniques. For example, in the production of a protein by genetic engineering, if the codons used in the original gene encoding the target protein are used infrequently in the host, the amount of protein produced may be low. In such cases, the amount of target protein produced can be increased by optimizing the codon usage frequency for the host without changing the encoded amino acid sequence.

[0046] The sum of the host-optimal codon usage frequencies for each codon can be used as an index of codon usage frequency. An optimal codon is defined as the codon with the highest usage frequency among codons corresponding to the same amino acid. The codon usage frequency is not particularly limited as long as it is optimized for the host. For example, the following is an example of an optimal codon for E. coli: F: phenylalanine (ttt), L: leucine (ctg), I: isoleucine (att), M: methionine (atg), V: valine (gtg), Y: tyrosine (tat), stop codon (taa), H: histidine (cat), Q: glutamine (cag), N: asparagine (aat), K: lysine (aaa), D: aspartic acid (gat), E: glutamic acid (gaa), S: serine (agc), P: proline (ccg), T: threonine (acc), A: alanine (gcg), C: cysteine ​​(tgc), W: tryptophan (tgg), R: arginine (cgc), G: glycine (ggc).

[0047] Methods for introducing a mutation into a gene and artificially modifying the amino acid sequence include known techniques such as the Kunkel method and the Gapped duplex method, and mutagenesis kits using site-directed mutagenesis, such as QuikChange™ Site-Directed Mutagenesis Kit (Stratagene), GeneTailor™ Site-Directed Mutagenesis System (Invitrogen), and TaKaRa Site-Directed Mutagenesis System (Mutan-K, Mutan-Super Express Km, etc.: Takara Bio Inc.).

[0048] The DNA base sequence can be confirmed by conventional sequencing, such as the dideoxynucleotide chain termination method (Sanger et al. (1977) Proc. Natl. Acad. Sci. USA 74:5463). Alternatively, the sequence can be analyzed using an appropriate DNA sequencer.

[0049] Whether the obtained DNA encodes the polypeptide of interest can be confirmed by comparing the determined nucleotide sequence with the nucleotide sequences set forth in SEQ ID NOs: 13 to 24. Alternatively, confirmation can be made by measuring the catalytic activity (carboxyl group-generating activity) of the expressed polypeptide.

[0050] (Method for producing a polycarboxylic acid-containing composition / method for producing a polycarboxylic acid-containing food) This embodiment relates to a method for producing a polycarboxylic acid-containing composition, comprising acting on a fatty acid-containing composition with a polypeptide shown in any one of (1) to (3) above or the above-mentioned carboxyl group-generating enzyme. This embodiment also relates to a method for producing a polycarboxylic acid-containing food, comprising acting on a fatty acid-containing food with a polypeptide shown in any one of (1) to (3) above or the above-mentioned carboxyl group-generating enzyme. In this embodiment, a polycarboxylic acid-containing composition or a polycarboxylic acid-containing food can be obtained by acting on a fatty acid-containing composition or a fatty acid-containing food with a carboxyl group-generating enzyme. The polycarboxylic acid-containing composition is preferably a dicarboxylic acid-containing composition, and the polycarboxylic acid-containing food is preferably a dicarboxylic acid-containing food. Furthermore, the fatty acid contained in the fatty acid-containing composition or the fatty acid-containing food is preferably a long-chain fatty acid. That is, a more preferred aspect of this embodiment relates to a method for producing a long-chain dicarboxylic acid-containing composition or a long-chain dicarboxylic acid-containing food.

[0051] This embodiment may relate to a method for producing a polycarboxylic acid-containing composition, comprising acting on an alcohol-containing composition with a polypeptide shown in any of (1) to (3) above or the above-mentioned carboxyl group-generating enzyme preparation. This embodiment also relates to a method for producing a polycarboxylic acid-containing food, comprising acting on an alcohol-containing food with a polypeptide shown in any of (1) to (3) above or the above-mentioned carboxyl group-generating enzyme preparation. In this embodiment, a polycarboxylic acid-containing composition or a polycarboxylic acid-containing food can be obtained by acting on an alcohol-containing composition or an alcohol-containing food with a carboxyl group-generating enzyme. The polycarboxylic acid-containing composition is preferably a dicarboxylic acid-containing composition, and the polycarboxylic acid-containing food is preferably a dicarboxylic acid-containing food. Furthermore, the alcohol contained in the alcohol-containing composition or the alcohol-containing food is preferably a long-chain aliphatic alcohol. That is, a more preferred aspect of this embodiment relates to a method for producing a long-chain dicarboxylic acid-containing composition or a long-chain dicarboxylic acid-containing food.

[0052] Furthermore, the carboxyl group-forming enzyme in this embodiment also catalyzes the shortening reaction of fatty acids. Therefore, the carboxyl group-forming enzyme may be a fatty acid shortening enzyme. That is, another aspect of this embodiment relates to a method for producing a processed fatty acid-containing composition, which comprises treating a fatty acid-containing composition with a fatty acid-shortening enzyme preparation containing a polypeptide described in any one of (1) to (3) above. For example, by treating a long-chain fatty acid-containing composition with a fatty acid shortening enzyme, it is possible to shorten long-chain fatty acids, thereby obtaining fatty acids with a carbon chain length shorter than that of the original long-chain fatty acids.

[0053] The carboxyl group-forming enzyme in this embodiment also catalyzes the shortening reaction of long-chain aliphatic alcohols. Therefore, the carboxyl group-forming enzyme may be a long-chain aliphatic alcohol shortening enzyme. That is, another aspect of this embodiment relates to a method for producing a processed alcohol-containing composition, which includes treating a long-chain aliphatic alcohol-containing composition with an enzymatic preparation for shortening long-chain aliphatic alcohols, the enzymatic preparation comprising a polypeptide described in any one of (1) to (3) above. For example, by treating a long-chain aliphatic alcohol-containing composition with a long-chain aliphatic alcohol shortening enzyme, it is possible to shorten the chain length of long-chain aliphatic alcohols, thereby obtaining aliphatic alcohols with a shorter carbon chain length than the carbon chain length of the original long-chain aliphatic alcohol.

[0054] In yet another aspect, the carboxyl group-generating enzyme in this embodiment catalyzes a reaction in which the alkyl group terminal of an alkane or fatty acid ester is hydroxylated or carboxylated to produce an alcohol or a carboxylic acid. Therefore, the carboxyl group-generating enzyme may be a hydroxyl group-generating enzyme. It is preferable that the alkyl group terminal of the alkane or fatty acid ester is hydroxylated and then carboxylated. That is, another aspect of this embodiment relates to a method for producing an alcohol-containing composition or a carboxylic acid-containing composition, which comprises treating an alkane-containing composition or a fatty acid ester-containing composition with a carboxyl group-generating enzyme preparation (hydroxyl group-generating enzyme preparation) containing a polypeptide described in any one of (1) to (3) above.

[0055] <Fatty Acid-Containing Composition / Fatty Acid-Containing Food> The fatty acid-containing composition contains a fatty acid. The fatty acid-containing composition may also be a composition containing a compound having a fatty acid in its partial structure. Here, fatty acids are classified into unsaturated fatty acids and saturated fatty acids, and unsaturated fatty acids are fatty acids having one or more carbon-carbon double bonds. Monounsaturated fatty acids are unsaturated fatty acids having only one carbon-carbon double bond. On the other hand, polyunsaturated fatty acids are unsaturated fatty acids having two or more carbon-carbon double bonds, and are divided into ω6 and ω3 types. Specifically, monounsaturated fatty acids include myristoleic acid, palmitoleic acid, oleic acid, gondoic acid, erucic acid, nervonic acid, hexacosenoic acid, and octacosenoic acid; ω3 polyunsaturated fatty acids include α-linolenic acid, stearidonic acid, eicosatetraenoic acid, eicosapentaenoic acid, and docosahexaenoic acid; and ω6 polyunsaturated fatty acids include linoleic acid, γ-linolenic acid, dihomo-γ-linolenic acid, arachidonic acid, and docosapentaenoic acid. Furthermore, fatty acids are classified into long-chain, medium-chain, and short-chain fatty acids based on their chain length. Long-chain fatty acids are fatty acids with 10 or more carbon atoms, and short-chain fatty acids are fatty acids with 6 or fewer carbon atoms.

[0056] Among these, the fatty acid is preferably a long-chain fatty acid, more preferably at least one selected from the group consisting of decanoic acid (capric acid), myristic acid, lauric acid, palmitic acid, palmitoleic acid, stearic acid, and oleic acid, and even more preferably decanoic acid or myristic acid. The fatty acid contained in the fatty acid-containing composition may be a single type or may contain multiple types.

[0057] When a composition containing a compound having a fatty acid in its partial structure is used as the fatty acid-containing composition, the compound having a fatty acid in its partial structure is preferably a fatty acid ester, more preferably a glyceride. That is, a composition containing a compound having an unsaturated long-chain fatty acid in its partial structure is preferably a fatty acid ester-containing composition, more preferably a glyceride-containing composition. Examples of glyceride-containing compositions include fats and oils. The glyceride-containing composition contains a glyceride, and triglycerides, diglycerides, and monoglycerides can be used as the glyceride. Note that a glyceride is formed by binding at least one fatty acid to glycerin.

[0058] In this embodiment, the fatty acid-containing composition may contain other optional components in addition to the fatty acid, or may consist of a fatty acid or a compound having a fatty acid in its partial structure. Examples of the other optional components include glycerin, salts (buffer salts), and hydrogen peroxide.

[0059] The fatty acid-containing composition may be a fatty acid-containing food.The fatty acid-containing food is a food or food material containing the above-mentioned fatty acid.Such food or food material includes edible oils (olive oil, safflower oil, sunflower oil, rapeseed oil, peanut oil, rice bran oil, etc.), meat (beef, chicken, pork, etc.), dairy products (cheese, processed milk, nut milk, yogurt), nuts (macadamia nuts, almonds, etc.), peanuts, sunflower seeds, eggs, egg products, olives, avocados, etc.

[0060] When the fatty acid-containing composition is a fatty acid-containing food, this embodiment relates to a method for producing a polycarboxylic acid-containing food, which comprises treating the fatty acid-containing food with the polypeptide shown in any one of (1) to (3) above or the above-mentioned carboxyl group-generating enzyme agent. Fatty acids contained in the fatty acid-containing food include the fatty acids mentioned above, and the preferred ranges are also the same. Furthermore, the polycarboxylic acid-containing food is preferably a dicarboxylic acid-containing food.

[0061] The fatty acid-containing composition may also contain, as other optional components, pH adjusters, preservatives, stabilizers, thickeners, antioxidants, surfactants, emulsifiers, solubilizers, solubilizers, bulking agents, suspending agents, salts (buffer salts), hydrogen peroxide, etc. Examples of pH adjusters include acetate buffer, phosphate buffer, MES buffer, HEPES buffer, PIPES buffer, Bis-tris buffer, MOPS buffer, etc.

[0062] The content of fatty acid contained in the fatty acid-containing composition or fatty acid-containing food is preferably 0.001% by mass or more, more preferably 0.002% by mass or more, even more preferably 0.01% by mass or more, even more preferably 0.1% by mass or more, even more preferably 1% by mass or more, even more preferably 5% by mass or more, and particularly preferably 10% by mass or more, based on the total mass of the fatty acid-containing composition or fatty acid-containing food.Furthermore, the content of fatty acid may be 100% by mass, 90% by mass or less, 80% by mass or less, 70% by mass or less, 60% by mass or less, or 50% by mass or less.

[0063] The form of the fatty acid-containing composition or fatty acid-containing food is not particularly limited as long as the enzyme reacts, and may be any of powder, solid, gel, and liquid (slurry) forms. Of these, the fatty acid-containing composition is preferably in liquid (slurry) form.

[0064] <Alcohol-Containing Composition / Alcohol-Containing Food> The alcohol-containing composition contains alcohol. The alcohol-containing composition may be a composition containing a compound having alcohol in its partial structure.

[0065] Among these, the alcohol is preferably a long-chain aliphatic alcohol, and the long-chain aliphatic alcohol is more preferably a polyhydric alcohol. Examples of long-chain aliphatic alcohols include aliphatic alcohols having 8 to 40 carbon atoms, which may have an even or odd number of carbon atoms. More specific examples include octanol, nonanol, decanol, undecanol, dodecanol, lauryl alcohol, myristyl alcohol, cetyl alcohol, oleyl alcohol, stearyl alcohol, and behenyl alcohol. The alcohol-containing composition may contain one type of alcohol alone or multiple types of alcohols.

[0066] In this embodiment, the alcohol-containing composition may contain other optional components in addition to alcohol, or may consist of alcohol or a compound having an alcohol as a partial structure. Examples of the other optional components include glycerin, salts (buffer salts), and hydrogen peroxide.

[0067] The alcohol-containing composition may be an alcohol-containing food product, which is a food or food ingredient containing the alcohol described above.

[0068] When the alcohol-containing composition is an alcohol-containing food, this embodiment relates to a method for producing a polycarboxylic acid-containing food, which comprises treating the alcohol-containing food with a polypeptide shown in any one of (1) to (3) above or the above-mentioned carboxyl group-generating enzyme agent. Examples of alcohol contained in the alcohol-containing food include the alcohols mentioned above, and the preferred ranges are also the same. In addition, the polycarboxylic acid-containing food is preferably a dicarboxylic acid-containing food.

[0069] The alcohol-containing composition may also contain other optional components such as pH adjusters, preservatives, stabilizers, thickeners, antioxidants, surfactants, emulsifiers, solubilizers, solubilizers, bulking agents, suspending agents, salts (buffer salts), hydrogen peroxide, etc. Examples of pH adjusters include acetate buffer, phosphate buffer, MES buffer, HEPES buffer, PIPES buffer, Bis-tris buffer, MOPS buffer, etc.

[0070] The alcohol content of the alcohol-containing composition or alcohol-containing food is preferably 0.001% by mass or more, more preferably 0.002% by mass or more, even more preferably 0.01% by mass or more, even more preferably 0.1% by mass or more, even more preferably 1% by mass or more, even more preferably 5% by mass or more, and particularly preferably 10% by mass or more, based on the total mass of the alcohol-containing composition or alcohol-containing food. Furthermore, the alcohol content may be 100% by mass, 90% by mass or less, 80% by mass or less, 70% by mass or less, 60% by mass or less, or 50% by mass or less.

[0071] The form of the alcohol-containing composition or alcohol-containing food is not particularly limited as long as the enzyme reacts, and may be any of powder, solid, gel, and liquid (slurry) forms. Of these, the alcohol-containing composition is preferably in liquid (slurry) form.

[0072] <Production Conditions for Polycarboxylic Acid-Containing Compositions or Polycarboxylic Acid-Containing Foods> In the step of reacting a fatty acid-containing composition or a fatty acid-containing food with a carboxyl group-forming enzyme, the reaction time, temperature, pH of the reaction solution, and the like are not particularly limited. Furthermore, in the step of reacting an alcohol-containing composition or an alcohol-containing food with a carboxyl group-forming enzyme, the reaction time, temperature, pH of the reaction solution, and the like are not particularly limited. The reaction temperature is, for example, 10 to 70°C, preferably 15 to 50°C, and more preferably 20 to 40°C. The pH of the reaction solution is, for example, 4 to 10, preferably 4.5 to 9, and more preferably 5 to 8. The reaction time is, for example, 30 seconds to 24 hours, preferably 1 minute to 12 hours, more preferably 10 minutes to 6 hours, or 30 minutes to 4 hours. The above reaction conditions enable the production of polycarboxylic acids to proceed more efficiently. These reaction conditions are appropriately selected depending on the desired polycarboxylic acid-containing composition. The optimal reaction conditions can be determined through preliminary experiments.

[0073] By using the production method of this embodiment, a composition or food containing polycarboxylic acid can be produced. One aspect of the production method of the polycarboxylic acid-containing composition or polycarboxylic acid-containing food of this embodiment includes, for example, the following steps (1) and (2): (1) a step of preparing a raw material containing fatty acid (fatty acid-containing composition or fatty acid-containing food); (2) a step of treating the prepared raw material with a carboxyl group-forming enzyme. Note that step (2) may be followed by (3) a step of inactivating the enzyme, and / or (4) a step of recovering the polycarboxylic acid. Step (2) may also be a step of treating in the presence of hydrogen peroxide.

[0074] Furthermore, one aspect of the method for producing a polycarboxylic acid-containing composition or a polycarboxylic acid-containing food of this embodiment includes, for example, the following steps (11) and (12): (11) a step of preparing a raw material containing alcohol (an alcohol-containing composition or an alcohol-containing food); and (12) a step of treating the prepared raw material with a carboxyl group-forming enzyme. Note that step (12) may be followed by (13) a step of inactivating the enzyme and / or (14) a step of recovering the polycarboxylic acid. Step (12) may also be a step of treating in the presence of hydrogen peroxide.

[0075] <Polycarboxylic Acid-Containing Composition / Polycarboxylic Acid-Containing Food> This embodiment may relate to a polycarboxylic acid-containing composition produced by the above-mentioned method for producing a polycarboxylic acid-containing composition. This embodiment may also relate to a polycarboxylic acid-containing food produced by the above-mentioned method for producing a polycarboxylic acid-containing food. The polycarboxylic acid-containing composition or polycarboxylic acid-containing food contains a polycarboxylic acid, and the polycarboxylic acid is preferably a dicarboxylic acid.

[0076] The polycarboxylic acid-containing composition or polycarboxylic acid-containing food may contain any component contained in the fatty acid-containing composition or fatty acid-containing food. The polycarboxylic acid-containing composition or polycarboxylic acid-containing food may be in the form of powder, solid, gel, or liquid (slurry). Among these, the dicarboxylic acid-containing composition is preferably in the form of liquid (slurry).

[0077] (Method for Carboxylating Fatty Acids) This embodiment relates to a method for carboxylating fatty acids, which comprises allowing a polypeptide described in any one of (1) to (3) above or the above-described enzyme agent for generating a carboxy group to act on a fatty acid. Examples of the fatty acid include the fatty acids described above, and the preferred ranges are also the same.

[0078] Furthermore, since the carboxyl group-producing enzyme in this embodiment also catalyzes the shortening reaction of fatty acids, the carboxyl group-producing enzyme may be a fatty acid shortening enzyme. That is, another aspect of this embodiment may relate to a method for shortening fatty acids, which comprises acting on a fatty acid with an enzymatic preparation for fatty acid shortening comprising the polypeptide described in any one of (1) to (3) above. In the method for shortening fatty acids, for example, by acting on a fatty acid shortening enzyme on a long-chain fatty acid, it is possible to shorten the chain of a long-chain fatty acid and obtain a fatty acid with a carbon chain length shorter than that of the original long-chain fatty acid.

[0079] In yet another aspect, the carboxyl group-generating enzyme in this embodiment catalyzes a reaction in which the alkyl group terminal of an alkane or a fatty acid ester is hydroxylated or carboxylated to produce an alcohol or a carboxylic acid. Therefore, the carboxyl group-generating enzyme may be a hydroxyl group-generating enzyme. That is, another aspect of this embodiment relates to a hydroxylation method or a carboxylation method, which includes treating an alkane-containing composition or a fatty acid ester-containing composition with a carboxyl group-generating enzymatic agent (hydroxyl group-generating enzymatic agent) containing the polypeptide described in any one of (1) to (3) above.

[0080] (Method for Carboxylating Alcohol) This embodiment relates to a method for carboxylating alcohol, which comprises reacting an alcohol with the polypeptide shown in any one of (1) to (3) above or the enzyme agent for generating a carboxy group described above. Examples of the alcohol include the alcohols described above, and the preferred ranges are also the same.

[0081] Furthermore, since the carboxyl group-forming enzyme in this embodiment also catalyzes the shortening reaction of long-chain aliphatic alcohols, the carboxyl group-forming enzyme may be a long-chain aliphatic alcohol shortening enzyme. That is, another aspect of this embodiment may relate to a method for shortening long-chain aliphatic alcohols, which comprises treating a long-chain aliphatic alcohol with an enzymatic agent for shortening long-chain aliphatic alcohols, the enzymatic agent comprising a polypeptide described in any one of (1) to (3) above. In the method for shortening long-chain aliphatic alcohols, for example, by treating a long-chain aliphatic alcohol with a long-chain aliphatic alcohol shortening enzyme, a long-chain alcohol can be shortened to obtain an alcohol with a shorter carbon chain length than the original long-chain alcohol.

[0082] The features of the present invention will be explained in more detail below with reference to examples and comparative examples. The materials, amounts used, ratios, treatment contents, treatment procedures, etc. shown in the following examples can be changed as appropriate without departing from the spirit of the present invention. Therefore, the scope of the present invention should not be construed as being limited by the specific examples shown below.

[0083] <Obtaining and Identifying Enzymes> (Selection of Carboxy-Group-Producing Enzymes) Candidates for carboxy-group-producing enzymes were selected from the NCBI protein database.

[0084] (Preparation of Carboxy-Group-Producing Enzyme) Codon-optimized synthetic genes were constructed based on the amino acid sequence of each candidate and the codon frequency of Aspergillus oryzae. A polyhistidine tag was added to the C-terminus and ligated to a filamentous fungal expression vector (pUC19 containing an A. oryzae-derived α-amylase promoter, an A. oryzae-derived glucose dehydrogenase terminator, and the pyrG gene). The constructed expression vector was introduced into Aspergillus oryzae by the protoplast-PEG method to obtain a transformant. The transformant was cultured in liquid at 30°C for 7 days. The resulting culture solution was filtered and purified using TALON Spin Columns (TaKaRa) and HisTALON™ Buffer Set. The crude enzyme solution was concentrated by ultrafiltration, and the pH was adjusted to a weak base using 0.5 volumes of 0.2 M Tris-HCl buffer (pH 8.2). This pH-adjusted solution was applied to a TALON Spin Column equilibrated with Equilibration Buffer. The column was washed with 8 mL of Equilibration Buffer and then eluted with 1 mL of Elution Buffer to obtain the purified enzyme shown below.

[0085] ・Carboxylic acid generating enzyme derived from Marasmius fiardii ・Carboxylic acid generating enzyme derived from Dendrothele bispora ・Carboxylic acid generating enzyme derived from Mycena venus ・Carboxylic acid generating enzyme derived from Armillaria ostoeae

[0086] (Test Example 1: Carboxylation Reaction with Each Enzyme) Acetate buffer (pH 5.5) (reaction concentration: 0.05 mM), substrate (myristic acid or decanoic acid: reaction concentration: 100 μM), and each of the purified enzymes described above were added to a 6 cc vial so that the reaction volume was 0.5 mL, and the final concentration was 0.09 to 20 μM. As a control, a reaction solution was also prepared using a known peroxygenase derived from Marasmius rotula (Marasmius rotula -derived UPO) as the enzyme. Thereafter, hydrogen peroxide was added to each reaction solution so that the reaction concentration was 10 mM, and the reaction was carried out at 30°C for 3 hours. The substrate was dissolved in acetonitrile, and the final concentration of acetonitrile in the reaction solution was 10% by mass. To 0.5 mL of the reaction solution, 1 mL of chloroform and 5 μL of 6N HCl were added and mixed thoroughly. 600 μL of the chloroform layer was transferred to a new vial and air-dried overnight. After distilling off the solvent, 300 μL of BSTFA-TMCS (99:1) (Tokyo Chemical Industry) was added to the vial and allowed to stand for at least 1 hour. 1 μL of this solution was injected into a GC-MS. The proportion of each product was calculated from the chromatographic peak area.

[0087] GCMS analysis conditions: Column: DB-5, Carrier gas: He, Column flow rate: 2.14 mL, Purge flow rate: 6.0 mL, Split ratio: 16.5, Interface temperature: 200°C, Vaporizer temperature: 250°C, Ion source temperature: 200°C, Column temperature: 50°C (1 min), -10°C / min (15 min), -50°C / min (2 min), -300°C (2 min)

[0088] (Results) When decanoic acid was used as a substrate, all enzymes produced decanedioic acid, confirming their carboxyl group-generating activity. In addition, some enzymes produced nonanoic acid, confirming that they also catalyzed the fatty acid shortening reaction.

[0089]

[0090] When myristic acid was used as a substrate, all enzymes were confirmed to produce dicarboxylic acids. Some enzymes produced dicarboxylic acids with shortened chains, confirming that they also catalyzed fatty acid shortening reactions.

[0091]

[0092] (Test Example 2: Carboxylation reaction of each substrate using Marasmius rotula-derived UPO) Acetate buffer (pH 5.5) (reaction concentration: 0.05 mM), substrate (lauric acid or dodecanol: reaction concentration: 100 μM), and each of the purified enzymes described above were added to a 6 cc vial so that the reaction volume was 0.5 mL. A control solution was also prepared in which Marasmius rotula-derived UPO was heat-inactivated. Hydrogen peroxide was then added to each reaction solution to a reaction concentration of 10 mM, and the reaction was carried out at 30°C for 3 hours. The substrate was dissolved in acetonitrile, and the final concentration of acetonitrile in the reaction solution was 10% by mass. To 0.5 mL of the reaction solution, 1 mL of chloroform and 5 μL of 6N HCl were added and mixed thoroughly. 600 μL of the chloroform layer was transferred to a new vial and air-dried overnight. After distilling off the solvent, 300 μL of BSTFA-TMCS (99:1) (Tokyo Chemical Industry) was added to the vial and allowed to stand for at least 1 hour. 1 μL of this solution was injected into a GC-MS. The proportion of each product was calculated from the chromatographic peak area.

[0093] GCMS analysis conditions: Column: DB-5, Carrier gas: He, Column flow rate: 2.14 mL, Purge flow rate: 6.0 mL, Split ratio: 16.5, Interface temperature: 200°C, Vaporizer temperature: 250°C, Ion source temperature: 200°C, Column temperature: 50°C (1 min), -10°C / min (15 min), -50°C / min (2 min), -300°C (2 min)

[0094] (Results) When dodecanol was used as a substrate, the consumption of the substrate was confirmed, and carboxyl group-forming activity was confirmed. Furthermore, when lauric acid was used as a substrate, the reduction of lauric acid was confirmed by this enzyme, suggesting that this enzyme also has the ability to produce dicarboxylic acids from lauric acid.

[0095] Qualitative analysis of the products when dodecanol was used as the substrate confirmed the production of lauric acid and 11-hydroxy lauric acid (Figure 1(a) Marasmius rotula-derived UPO and Figure 1(b) control).

[0096] *Production amount = {(Peak area of ​​product when enzyme is used / (Peak area of ​​internal standard substance)} - {Peak area when heat-inactivated enzyme is used) / (Peak area of ​​internal standard substance)} *Internal standard substance: oleic acid Final concentration: 100 μM

[0097] SEQ ID NO: 1: Mature sequence of Cloroperoxidase derived from Marasmius fiardii PR-910 (Accession No. KAF9265234.1) DDEVDFSAHAWQAPGPNDSRSPCPGLNTLANHGFLPRNGKNISIPMIIQAGHDGYHFEADILTIAAKVGLLTSPDDQPTTLSLNDLKAHGVLEHDASLSRQDFALGDNVHFNETLFSTLTNSNPGYDVYNITSAGQVQRARLADSVQNNPNITNTDTTLFIRSAESAFYLSAMGDPIKGVAPKNFVQIFFREERMPIEEGWKRSSTPVTADTLVPLINQITAASQPWEPSGKNCPGILP

[0098] SEQ ID NO: 2: Mature sequence of SEQ ID NO: 1 + His tag DDEVDFSAHAWQAPGPNDSRSPCPGLNTLANHGFLPRNGKNISIPMIIQAGHDGYHFEADILTIAAKVGLLTSPDDQPTTLSLNDLKAHGVLEHDASLSRQDFALGDNVHFNETLFSTLTNSNPGYDVYNITSAGQVQRARLADSVQNNPNITNTDTTLFIRSAESAFYLSAMGDPIKGVAPKNFVQIFFREERMPIEEGWKRSSTPVTADTLVPLINQITAASQPWEPSGKNCPGILPHHHHHH

[0099] SEQ ID NO: 3: Mature sequence of SEQ ID NO: 1 + signal sequence + His tag MKLLSSLVFIAVASTALADDEVDFSAHAWQAPGPNDSRSPCPGLNTLANHGFLPRNGKNISIPMIIQAGHDGYHFEADILTIAAKVGLLTSPDDQPTTLSLNDLKAHGVLEHDASLSRQDFALGDNVHFNETLFSTLTNSNPGYDVYNITSAGQVQRARLADSVQNNPNITNTDTTLFIRSAESAFYLSAMGDPIKGVAPKNFVQIFFREERMPIEEGWKRSSTPVTADTLVPLINQITAASQPWEPSGKNCPGILPHHHHHH

[0100] SEQ ID NO: 4: Mature sequence of Cloroperoxidase derived from Dendrothele bispora CBS 962.96 (Accession No. THU90505.1) KNGSAEIDWDAHQWQAPGPNDLRGPCPGLNTLANHGFLPRDGRNLNMSVIVDAGFDGYHMQPDVLALAVKVAFLTTDDPFSFTLDDIKLHETIEHDASLSREDFALGDNLHFNETIFSTLANSNPGSDFYNTTSAGEVQRLRLADSEARNPNVTNTDKEFFIRSAESGFYLSVMGDPLAGVAPKEFVQIFFREERLPIAEGWHRSETPINSTTLGPLIGKIEAASNWTTSGGCPIIVLGPDFGSF

[0101] SEQ ID NO: 5: Mature sequence of SEQ ID NO: 4 plus His tag KNGSAEIDWDAHQWQAPGPNDLRGPCPGLNTLANHGFLPRDGRNLNMSVIVDAGFDGYHMQPDVLALAVKVAFLTTDDPFSFTLDDIKLHETIEHDASLSREDFALGDNLHFNETIFSTLANSNPGSDFYNTTSAGEVQRLRLADSEARNPNVTNTDKEFFIRSAESGFYLSVMGDPLAGVAPKEFVQIFFREERLPIAEGWHRSETPINSTTLGPLIGKIEAASNWTTSGGCPIIVLGPDFGSFHHHHHH

[0102] SEQ ID NO: 6: Mature sequence of SEQ ID NO: 4 + signal sequence + His tag MLSKSLLLSFCTTALLASVASAKNGSAEIDWDAHQWQAPGPNDLRGPCPGLNTLANHGFLPRDGRNLNMSVIVDAGFDGYHMQPDVLALAVKVAFLTTDDPFSFTLDDIKLHETIEHDASLSREDFALGDNLHFNETIFSTLANSNPGSDFYNTTSAGEVQRLRLADSEARNPNVTNTDKEFFIRSAESGFYLSVMGDPLAGVAPKEFVQIFFREERLPIAEGWHRSETPINSTTLGPLIGKIEAASNWTTSGGCPIIVLGPDFGSFHHHHHH

[0103] SEQ ID NO: 7: Mature sequence of Mycena venus-derived hypothetical protein (Accession No. KAF7362512.1) STIDNHQWIAPKATDVRSPCPGLNTLANHGYLPRDGRNISIPMMVQAALDGFNVGVDAILQAAKFGLLSTDDLMTLNLDALKLHNLIEHDASLSRNDLAVTGDNLHFNETIFTTLANSNPGVDYYDPTSAGQVQHDRLAISLATNPNITNTAKEFIVRTRESSFYLSVMGNPLTGVAPKQFVNIFFREERLPIAEGWKKSTTVITGEILNPIMDVIIDNSNWTMTQLCEDLVLGPNLTF

[0104] SEQ ID NO: 8: Mature sequence of SEQ ID NO: 7 plus His tag STIDNHQWIAPKATDVRSPCPGLNTLANHGYLPRDGRNISIPMMVQAALDGFNVGVDAILQAAKFGLLSTDDLMTLNLDALKLHNLIEHDASLSRNDLAVTGDNLHFNETIFTTLANSNPGVDYYDPTSAGQVQHDRLAISLATNPNITNTAKEFIVRTRESSFYLSVMGNPLTGVAPKQFVNIFFREERLPIAEGWKKSTTVITGEILNPIMDVIIDNSNWTMTQLCEDLVLGPNLTFHHHHHH

[0105] SEQ ID NO: 9: Mature sequence of SEQ ID NO: 7 + signal sequence + His tag MNLLLVSLFLVAVATAKGSTIDNHQWIAPKATDVRSPCPGLNTLANHGYLPRDGRNISIPMMVQAALDGFNVGVDAILQAAKFGLLSTDDLMTLNLDALKLHNLIEHDASLSRNDLAVTGDNLHFNETIFTTLANSNPGVDYYDPTSAGQVQHDRLAISLATNPNITNTAKEFIVRTRESSFYLSVMGNPLTGVAPKQFVNIFFREERLPIAEGWKKSTTVITGEILNPIMDVIIDNSNWTMTQLCEDLVLGPNLTFHHHHHH

[0106] SEQ ID NO: 10: Mature sequence of Cloroperoxidase from Armillaria ostoyae (Accession No. SJL09533.1) TVDWKLHEWQAPGASDLRGPCPGLNTLANHGFLPRDGKNITIKMVLDAGLEGFNIDPSILILAAKVGLLTTNAPDSFTLDDLKLHGTIEHDASLSRSDFLLGDNLHFNETIYTTLTQSNPGVDYFNATSAGQVQKKRLADDIIANPGIINTIKEFTVRTRESALYLSVMGDPVTGIAPKKFVDIFFREERMPIEEGWTQPSTLITGQTISPIADIIEETSEWVDNGGCPIIRPGPNSDLISCP

[0107] SEQ ID NO: 11: Mature sequence of SEQ ID NO: 10 + His tag TVDWKLHEWQAPGASDLRGPCPGLNTLANHGFLPRDGKNITIKMVLDAGLEGFNIDPSILILAAKVGLLTTNAPDSFTLDDLKLHGTIEHDASLSRSDFLLGDNLHFNETIYTTLTQSNPGVDYFNATSAGQVQKKRLADDIIANPGIINTIKEFTVRTRESALYLSVMGDPVTGIAPKKFVDIFFREERMPIEEGWTQPSTLITGQTISPIADIIEETSEWVDNGGCPIIRPGPNSDLISCPHHHHH

[0108] SEQ ID NO: 12: Mature sequence of SEQ ID NO: 10 + signal sequence + His tag MYLSLTFVAAFFSAVHATVDWKLHEWQAPGASDLRGPCPGLNTLANHGFLPRDGKNITIKMVLDAGLEGFNIDPSILILAAKVGLLTTNAPDSFTLDDLKLHGTIEHDASLSRSDFLLGDNLHFNETIYTTLTQSNPGVDYFNATSAGQVQKKRLADDIIANPGIINTIKEFTVRTRESALYLSVMGDPVTGIAPKKFVDIFFREERMPIEEGWTQPSTLITGQTISPIADIIEETSEWVDNGGCPIIRPGPNSDLISCPHHHHHH

[0109] SEQ ID NO: 13: Nucleotide sequence (cDNA sequence) encoding the mature sequence of Cloroperoxidase (Accession No. KAF9265234.1) derived from Marasmius fiardii PR-910 gatgatgaggtggatttcagtgctcacgcttggcaagctccaggcccgaacgatagtcgatccccatgtcctggccttaacacactcgccaatcatggctttctaccacgcaatggcaagaatatctcgattcccatgatcatccaggcaggacatgacgggtatcacttcgaggcagatatcctgactatcgctgcgaaagttgggctcttgacgagtccagacgatcaacctaccacattgtcccttaacgacctgaaagcccatggtgtactggagcatgacgcttcgctaagcagacaggactttgcattaggcgacaacgtgcacttcaacgagactctcttttccacgctgaccaatagcaatccaggttatgacgtgtacaacatcacctcagcaggtcaagtgcaacgtgccaggcttgcggatagcgtccagaacaatccgaacattaccaatacagacacgacgctcttcattcgctctgccgaatcggcgttttacctgtctgcgatgggagatccgataaagggtgtagcacccaagaacttcgtccagatcttctttcgggaagagcgtatgccgattgaggaagggtggaaacggagctcaacccctgttactgccgatacacttgtccccttgatcaaccagataaccgctgcatctcagccctgggaaccctctggaaagaattgccctggaattcttcct

[0110] SEQ ID NO: 14: The nucleotide sequence encoding the mature sequence of SEQ ID NO: 13 + His tag gatgatgaggtggatttcagtgctcacgcttggcaagctccaggcccgaacgatagtcgatccccatgtcctggccttaacacactcgccaatcatggctttctaccacgcaatggcaagaatatctcgattcccatgatcatccaggcaggacatgacgggtatcacttcgaggcagatatcctgactatcgctgcgaaagttgggctcttgacgagtccagacgatcaacctaccacattgtcccttaacgacctgaaagcccatggtgtactggagcatgacgcttcgctaagcagacaggactttgcattaggcgacaacgtgcacttcaacgagactctcttttccacgctgaccaatagcaatccaggttatgacgtgtacaacatcacctcagcaggtcaagtgcaacgtgccaggcttgcggatagcgtccagaacaatccgaacattaccaatacagacacgacgctcttcattcgctctgccgaatcggcgttttacctgtctgcgatgggagatccgataaagggtgtagcacccaagaacttcgtccagatcttctttcgggaagagcgtatgccgattgaggaagggtggaaacggagctcaacccctgttactgccgatacacttgtccccttgatcaaccagataaccgctgcatctcagccctgggaaccctctggaaagaattgccctggaattcttcctcaccatcaccatcatcattag

[0111] SEQ ID NO: 15: Nucleotide sequence encoding the mature sequence of SEQ ID NO: 13 + signal sequence + His tag atgaagctcttgtcatcgctagtcttcattgccgttgcttccactgcgttagccgatgatgaggtggatttcagtgctcacgcttggcaagctccaggcccgaacgatagtcgatccccatgtcctggccttaacacactcgccaatcatggctttctaccacgcaatggcaagaatatctcgattcccatgatcatccaggcaggacatgacgggtatcacttcgaggcagatatcctgactatcgctgcgaaagttgggctcttgacgagtccagacgatcaacctaccacattgtcccttaacgacctgaaagcccatggtgtactggagcatgacgcttcgctaagcagacaggactttgcattaggcgacaacgtgcacttcaacgagactctcttttccacgctgaccaatagcaatccaggttatgacgtgtacaacatcacctcagcaggtcaagtgcaacgtgccaggcttgcggatagcgtccagaacaatccgaacattaccaatacagacacgacgctcttcattcgctctgccgaatcggcgttttacctgtctgcgatgggagatccgataaagggtgtagcacccaagaacttcgtccagatcttctttcgggaagagcgtatgccgattgaggaagggtggaaacggagctcaacccctgttactgccgatacacttgtccccttgatcaaccagataaccgctgcatctcagccctgggaaccctctggaaagaattgccctggaattcttcctcaccatcaccatcatcattag

[0112] SEQ ID NO: 16: Nucleotide sequence (cDNA sequence) encoding the mature sequence of Cloroperoxidase (Accession No. THU90505.1) derived from Dendrothele bispora CBS 962.96 aagaatggctcggcagagattgattgggatgcacatcagtggcaagcacctggacccaatgacctgagaggaccttgtccagggctcaacacgttggctaatcacggtttccttcctcgtgatggtcgaaacctcaatatgtcggtgattgtggatgccggatttgacggctatcacatgcaaccggatgtactcgctttggcggtcaaagtcgcgttcttgaccactgatgaccccttttccttcacactcgacgatatcaagctccatgagacgatcgagcatgacgcttctctgtcacgggaagactttgcgctaggggataaccttcacttcaacgaaaccatcttctctacactcgccaacagcaatccgggttccgacttctacaacacgacttcagcaggcgaagtacagcgtttacgccttgcggatagtgaagcccgaaacccgaatgtgacgaacacagacaaagagttctttattcgcagtgcggaatccggcttctacctgtcggttatgggcgatccacttgccggagttgctccaaaggagttcgtccagatcttctttcgcgaggagaggcttcccatagctgagggttggcatcggtcagaaacccccataaacagcaccacactgggaccactcattgggaagattgaagcagccagcaattggaccacttctggtggttgcccgatcatcgttttggggcctgactttggcagtttt

[0113] SEQ ID NO: 17: The nucleotide sequence encoding the mature sequence of SEQ ID NO: 16 + His tag aagaatggctcggcagagattgattgggatgcacatcagtggcaagcacctggacccaatgacctgagaggaccttgtccagggctcaacacgttggctaatcacggtttccttcctcgtgatggtcgaaacctcaatatgtcggtgattgtggatgccggatttgacggctatcacatgcaaccggatgtactcgctttggcggtcaaagtcgcgttcttgaccactgatgaccccttttccttcacactcgacgatatcaagctccatgagacgatcgagcatgacgcttctctgtcacgggaagactttgcgctaggggataaccttcacttcaacgaaaccatcttctctacactcgccaacagcaatccgggttccgacttctacaacacgacttcagcaggcgaagtacagcgtttacgccttgcggatagtgaagcccgaaacccgaatgtgacgaacacagacaaagagttctttattcgcagtgcggaatccggcttctacctgtcggttatgggcgatccacttgccggagttgctccaaaggagttcgtccagatcttctttcgcgaggagaggcttcccatagctgagggttggcatcggtcagaaacccccataaacagcaccacactgggaccactcattgggaagattgaagcagccagcaattggaccacttctggtggttgcccgatcatcgttttggggcctgactttggcagttttcaccatcaccatcatcattag

[0114] SEQ ID NO: 18: Nucleotide sequence encoding the mature sequence of SEQ ID NO: 16 + signal sequence + His tag

[0115] SEQ ID NO: 19: Nucleotide sequence (cDNA sequence) encoding the mature sequence of hypothetical protein from Mycena venus (Accession No. KAF7362512.1) tctacgattgacaatcaccagtggattgcacctaaagcgacggatgtccggtcaccatgtcctgggctgaatacacttgcaaaccatggctatctgcctagggatggccgcaacatcagtataccgatgatggtccaagctgccttagacgggttcaatgtaggtgtcgatgcgattctacaagccgctaagtttggccttctaagcactgatgatctcatgacccttaacttggatgccttgaagttacacaacctgatcgagcatgatgccagtttgtcccgtaacgacttggcagtgacaggagacaaccttcacttcaacgagacaatcttcacgacacttgcgaattccaatccaggtgttgactactatgaccccacttcagctggacaagtgcagcatgatcgactcgcaattagcttggcaaccaatcccaacataaccaataccgccaaggagttcatcgtcagaacgcgggaatcttcgttctacctctcggttatgggcaatccgcttactggtgttgctccgaaacagttcgtgaacatcttctttcgcgaagaacgtctgccaattgctgaagggtggaagaagagcactaccgtcattacgggagagatcctgaatcccataatggacgtcatcatcgacaactctaactggaccatgactcagctatgcgaggatctcgtgctcggtcctaatctcaccttt

[0116] Array number 20: Nucleotide sequence encoding the mature sequence of array number 19 + His tag tctacgattgacaatcaccagtggattgcacctaaagcgacggatgtccggtcaccatgtcctgggctgaatacacttgcaaaccatggctatctgcctagggatggccgcaacatcagtataccgatgatggtccaagctgccttagacgggttcaatgtaggtgtcgatgcgattctacaagccgctaagtttggccttctaagcactgatgatctcatgacccttaacttggatgccttgaagttacacaacctgatcgagcatgatgccagtttgtcccgtaacgacttggcagtgacaggagacaaccttcacttcaacgagacaatcttcacgacacttgcgaattccaatccaggtgttgactactatgaccccacttcagctggacaagtgcagcatgatcgactcgcaattagcttggcaaccaatcccaacataaccaataccgccaaggagttcatcgtcagaacgcgggaatcttcgttctacctctcggttatgggcaatccgcttactggtgttgctccgaaacagttcgtgaacatcttctttcgcgaagaacgtctgccaattgctgaagggtggaagaagagcactaccgtcattacgggagagatcctgaatcccataatggacgtcatcatcgacaactctaactggaccatgactcagctatgcgaggatctcgtgctcggtcctaatctcacctttcaccatcaccatcatcattag

[0117] SEQ ID NO: 21: Nucleotide sequence encoding the mature sequence of SEQ ID NO: 19 + signal sequence + His tag

[0118] SEQ ID NO: 22: Nucleotide sequence (cDNA sequence) encoding the mature sequence of Cloroperoxidase from Armillaria ostoyae (Accession No. SJL09533.1) actgtcgattggaaacttcacgaatggcaagctccaggagcatcggacttacgtggtccttgtccgggattgaacactttggccaatcacggctttctacccagagacggaaagaacattacgatcaagatggtgcttgatgccggtctagagggattcaacatagatccctccatcctgattttggctgccaaagtcggcttactcaccacaaatgcaccagacagctttacgcttgatgacctgaagctgcatgggaccattgagcatgatgcgtctttgtcacgctctgatttcctcctcggtgataacttgcacttcaatgagacgatctacaccacccttacgcagtccaatcctggtgtggactacttcaacgcgacatctgctggccaagtccagaaaaaacggcttgcggatgacatcattgccaacccagggatcatcaacaccattaaggagttcacagttcgaacgcgggaaagtgccctctatctctccgtaatgggcgatccagttactggcattgctcccaagaagttcgtggacatattctttcgcgaagagaggatgcctattgaagagggatggactcaaccgagtaccctaatcacagggcagacaatctcgcctatagctgacatcatcgaggaaacttcggaatgggtcgataatggtggctgcccgattatccgtcctggtccgaatagcgacctgatcagctgcccc

[0119] SEQ ID NO: 23: The nucleotide sequence encoding the mature sequence of SEQ ID NO: 22 + His tag actgtcgattggaaacttcacgaatggcaagctccaggagcatcggacttacgtggtccttgtccgggattgaacactttggccaatcacggctttctacccagagacggaaagaacattacgatcaagatggtgcttgatgccggtctagagggattcaacatagatccctccatcctgattttggctgccaaagtcggcttactcaccacaaatgcaccagacagctttacgcttgatgacctgaagctgcatgggaccattgagcatgatgcgtctttgtcacgctctgatttcctcctcggtgataacttgcacttcaatgagacgatctacaccacccttacgcagtccaatcctggtgtggactacttcaacgcgacatctgctggccaagtccagaaaaaacggcttgcggatgacatcattgccaacccagggatcatcaacaccattaaggagttcacagttcgaacgcgggaaagtgccctctatctctccgtaatgggcgatccagttactggcattgctcccaagaagttcgtggacatattctttcgcgaagagaggatgcctattgaagagggatggactcaaccgagtaccctaatcacagggcagacaatctcgcctatagctgacatcatcgaggaaacttcggaatgggtcgataatggtggctgcccgattatccgtcctggtccgaatagcgacctgatcagctgcccccaccatcaccatcatcattag

[0120] SEQ ID NO: 24: Nucleotide sequence encoding the mature sequence of SEQ ID NO: 22 + signal sequence + His tag

Claims

1. An enzyme preparation for generating a carboxy group, comprising a polypeptide shown in any one of (1) to (3) below: (1) A polypeptide consisting of an amino acid sequence shown in any one of SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10 and 11; (2) A polypeptide in which one or more amino acid residues have been substituted, added, inserted and / or deleted in an amino acid sequence shown in any one of SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10 and 11, and which has carboxy group generating activity; (3) A polypeptide which has a sequence identity of 90% or more to an amino acid sequence shown in any one of SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10 and 11, and which has carboxy group generating activity.

2. The enzyme preparation for generating a carboxy group according to claim 1, which is used for generating a dicarboxylic acid.

3. A method for producing a polyvalent carboxylic acid-containing composition, comprising reacting a fatty acid-containing composition with the polypeptide or carboxyl group-generating enzyme agent described in claim 1 or 2.

4. The method for producing a polyvalent carboxylic acid-containing composition according to claim 3, wherein the fatty acid-containing composition contains decanoic acid or myristic acid.

5. The method for producing a polycarboxylic acid-containing composition according to claim 3, wherein the polycarboxylic acid-containing composition is a dicarboxylic acid-containing composition.

6. A method for carboxylating a fatty acid, which comprises reacting a polypeptide or a carboxy group-generating enzyme preparation according to claim 1 or 2 with the fatty acid.

7. A method for producing a polyvalent carboxylic acid-containing food, comprising reacting a fatty acid-containing food with the polypeptide or a carboxyl group-generating enzyme preparation according to claim 1 or 2.

8. A method for producing a polycarboxylic acid-containing food according to claim 7, wherein the polycarboxylic acid-containing food is a dicarboxylic acid-containing food.

Citation Information

Patent Citations

  • Method for producing dicarboxylic acid

    JP2006262728A

  • Method for producing long-chain dicarboxylic acid

    JP2014168440A

  • Enzymatic preparation of diols

    WO2013004639A2